Nagoshi, Sumiko

Publishing since 2004 (Junior)

Has published 15 publications in 7 years

Number of publications published per year by Nagoshi, Sumiko. (Source : PubMed)

Distribution of publications types for Nagoshi, Sumiko. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Nagoshi S, Nakazawa T. [Professional activity of women in medicine]  Nippon Shokakibyo Gakkai Zasshi  2010;107;1  
•  Nakashima S, Ota S, Arai S, Yoshino K, Inao M, Ishikawa K, Nakayama N, Imai Y, Nagoshi S, Mochida S. Usefulness of anti-ulcer drugs for the prevention and treatment of peptic ulcers induced by low doses of aspirin.  World J. Gastroenterol.  2009;15;6  
•  Mochida S, Nakayama N, Matsui A, Nagoshi S, Fujiwara K. Re-evaluation of the Guideline published by the Acute Liver Failure Study Group of Japan in 1996 to determine the indications of liver transplantation in patients with fulminant hepatitis.  Hepatol. Res.  2008;38;10  
•  Fujiwara K, Mochida S, Matsui A, Nakayama N, Nagoshi S, Toda G. Fulminant hepatitis and late onset hepatic failure in Japan.  Hepatol. Res.  2008;38;7  
•  Nagoshi S. Sex- or gender-specific medicine in hepatology.  Hepatol. Res.  2008;38;3  
•  Nagoshi S, Mochuda S, Fujiwara K. [Anti-viral therapy of type B chronic hepatitis. 2. Development of a fulminant form: its mechanism and treatment]  Nippon Naika Gakkai Zasshi  2008;97;1  
•  Koike M, Takahashi K, Mishiro S, Matsui A, Inao M, Nagoshi S, Ohno A, Mochida S, Fujiwara K. Full-length sequences of two hepatitis E virus isolates representing an Eastern China-indigenous subgroup of genotype 4.  Intervirology  2007;50;3  
•  Nagoshi S, Fujiwara K. [Medical accidents involving diagnostic and therapeutic use of endoscopy of the digestive system and measures to be taken for safety (data from the Ministry of Health, Labor and Welfare)]  Nippon Naika Gakkai Zasshi  2006;95;7  
•  Koh HS, Matsui A, Mimura S, Inao M, Saitoh E, Ohno A, Nagoshi S, Yoshimoto T, Mochida S, Fujiwara K. Increased cytoprotective function in the liver of transgenic mice expressing osteopontin in hepatocytes.  Hepatol. Res.  2005;32;1  
•  Naito M, Matsui A, Inao M, Nagoshi S, Nagano M, Ito N, Egashira T, Hashimoto M, Mishiro S, Mochida S, Fujiwara K. SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C.  J. Gastroenterol.  2005;40;4  

[ See timeline ] [ See all publications ]